Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Ocugen (OCGN) over the last 7 years, with Q3 2025 value amounting to $304.0 million.

  • Ocugen's Shares Outstanding (Diluted Average) rose 928.62% to $304.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $304.0 million, marking a year-over-year increase of 928.62%. This contributed to the annual value of $271.0 million for FY2024, which is 1091.49% up from last year.
  • As of Q3 2025, Ocugen's Shares Outstanding (Diluted Average) stood at $304.0 million, which was up 928.62% from $292.1 million recorded in Q2 2025.
  • Ocugen's 5-year Shares Outstanding (Diluted Average) high stood at $304.0 million for Q3 2025, and its period low was $186.3 million during Q1 2021.
  • For the 5-year period, Ocugen's Shares Outstanding (Diluted Average) averaged around $239.2 million, with its median value being $238.3 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 13411.32% in 2021, then soared by 799.05% in 2024.
  • Quarter analysis of 5 years shows Ocugen's Shares Outstanding (Diluted Average) stood at $195.0 million in 2021, then grew by 10.04% to $214.6 million in 2022, then rose by 13.85% to $244.3 million in 2023, then rose by 10.91% to $271.0 million in 2024, then rose by 12.18% to $304.0 million in 2025.
  • Its last three reported values are $304.0 million in Q3 2025, $292.1 million for Q2 2025, and $292.0 million during Q1 2025.